Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Comirnaty (tozinameran) Disease area(s): Vaccines/infectious diseases Manufacturer(s): Pfizer/BioNTech 2024 Sales (USD ): $7.79 billion Why it sold so well: In 2024, Pfizers COVID-19 vaccine, Comirnaty, generated $3.38 billion in revenue during the fourth quarter, surpassing expectations by approximately $280 million, and $5.35 billion for the year
Weight loss following gastric bypass surgery resulted in the differential expression of TCF7L2 mRNA isoforms in subcutaneous fat (270)
Clinical Weight Loss Data In 2024, a systematic review (which collects existing data and draws broader conclusions) found that using semaglutide for weight loss vs
Clinical characteristics, predictors, and outcomes of heart failure with improved ejection fraction
What You Need to Know Evaluating semaglutide vs exenatide: complete head-to-head comparison requires looking at clinical trial data, real-world patient reports, cost differences, and practical convenience factors simultaneously
US$ 22.85
US$ 20.93
US$ 22.59
